FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Hikal LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:524735 P/E (TTM) :270.84
ISIN Demat:INE475B01022 Div & Yield %:0.36 EPS (TTM) :0.83
Book Value (RS) :96.8412723 Market Cap (Rs Cr.):2771.8 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 316.20 450.80 -29.86
Other Income 1.90 0.40 375.00
PBIDT 9.30 75.10 -87.62
Interest 14.90 18.80 -20.74
PBDT -5.60 56.30 -109.95
Depreciation 41.20 31.70 29.97
PBT -46.80 24.60 -290.24
Tax 0.00 6.70 -100.00
Deferred Tax -12.10 -0.20 0.00
PAT -34.70 18.10 -291.71

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)